<DOC>
	<DOCNO>NCT01651234</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability characterize PK , PD f\profile .</brief_summary>
	<brief_title>A Study Assess Safety , Tolerability , Pharmacokinetics Orally Administered GCC4401C Healthy Volunteers</brief_title>
	<detailed_description>The primary objective study investigate safety tolerability follow administration single ascend dos GCC4401C healthy male subject ; secondary objective study characterize single-dose PK profile oral administration GCC-4401C , determine appropriate dose range dose regimen oral GCC-4401C subsequent clinical trial .</detailed_description>
	<criteria>1 . Capable understand complying requirement study sign informed consent form ( ICF ) ; 2 . Normal healthy male 18 55 year age , inclusive , time consent ; 3 . A body mass index ( BMI ) least 18.5 kg/m2 30 kg/m2 ( BMI define subject 's weight kilogram divide square root subject 's height meter ) ; 4 . In general good health base screen medical history , physical examination ( defined absence clinically significant abnormality ) , vital sign , clinical laboratory value ( hematology , serum chemistry , urinalysis ) ; 5 . Have normal ECG ( define Fridericia 's correction QT interval [ QTcF ] less equal 450 m ) screening , Day 1 Day 1 , predose ( baseline ) . Repeat ECG measurement allow baseline assessment QTcF value 450 m average use assess eligibility . 6 . Male subject must use barrier contraception sexual intercourse , ie , condom , first day dose 3 month last dosing GCC4401C ; 7 . Nonsmokers ( define smoke used nicotine contain product least 1 month , urine cotinine le 400 ng/mL ) . Subjects present follow enter study : 1 . Have clinically significant abnormal history , physical finding , laboratory value prestudy screen assessment could interfere objective study safety subject ; 2 . Have follow , may put increase risk anticoagulant use : family history personal history bleed disorder diseases/syndromes either alter increase propensity bleeding ; severe trauma , fracture , major surgery , biopsy parenchymal organ within past 3 month ; endoscopic pepticulcer disease within past 3 year clinically significant gastrointestinal , genitourinary , gum bleeding within past 3 month ; personal history vascular abnormality include aneurysm ; personal history severe hemorrhage , hematemesis , melena , hemoptysis , severe epistaxis , severe thrombocytopenia , intracranial hemorrhage ; rectal bleeding within 3 month prior screen ; history thrombotic hemorrhagic stroke ; clinically significant laboratory abnormality ( hemoglobin le 12.0 g/dL , prolong PT INR , prolong aPTT , elevate liver enzyme , elevate serum creatinine blood urea nitrogen ( BUN ) consider clinically significant Investigator , platelet count le 150,000/mm3 great 600,000/mm3 ) . Mildly elevate BUN normal serum creatinine value determine clinical significant Investigator permit . These significant laboratory value may repeat confirmation ; contraindication anticoagulant treatment , increase bleeding risk , judge Investigator . 3 . Have know positive test hepatitis B surface antigen , hepatitis C antibody , human immunodeficiency virus ( HIV ) 1 , HIV 2 ; 4 . Are consider schedule undergo surgical procedure study ; 5 . Have receive investigational product within 30 day prior dose ; 6 . Presence history severe adverse reaction drug ; 7 . Involvement plan and/or conduct study ; 8 . Positive urine drug screen urine alcohol screen medical screening checkin ; 9 . History alcohol , drug , substance abuse , define Diagnostic Statistical Manual Mental Disorders , 4th Edition past 12 month ; 10 . Positive test result fecal occult blood , measure screen and/or checkin clinic ; 11 . Consumption alcohol within 48 hour prior dose ; 12 . Intake 14 unit ( unit 12 oz beer , 5 oz wine , 1.5 oz liquor ) alcohol per week ; 13 . Use drug induce inhibit cytochrome P450 Pglycoprotein within 30 day prior dose ; 14 . Use prescribed overthecounter ( OTC ) medication include antacid , analgesic , herbal remedy , vitamin , mineral ( exception 3 gram acetaminophen ) medication contain aspirin nonsteroidal antiinflammatory medication anticoagulant effect within 2 week prior dose ; 15 . Any intake grapefruit , grapefruit juice , Seville oranges , Seville orange marmalade , product contain grapefruit Seville oranges within 7 day dose ; 16 . Planning father child donate sperm study 3 month follow dosing ; 17 . Do vein suitable cannulation multiple venipuncture ; 18 . Have previously participate study ; 19 . Donation plasma blood product within 1 month screen blood donation/blood loss great 450 mL 3 month prior screen ; 20 . Any factor Investigator think increase subject risk participation .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2012</verification_date>
</DOC>